Transdermal testosterone treatment in women with impaired sexual function after oophorectomy

被引:612
作者
Shifren, JL
Braunstein, GD
Simon, JA
Casson, PR
Buster, JE
Redmond, GP
Burki, RE
Ginsburg, ES
Rosen, RC
Leiblum, SR
Caramelli, KE
Mazer, NA
Jones, KP
Daugherty, CA
机构
[1] Massachusetts Gen Hosp, Vincent Mem Obstet & Gynecol Serv, Dept Obstet & Gynecol, Boston, MA 02114 USA
[2] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA
[3] Womens Hlth Res Ctr, Laurel, MD USA
[4] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA
[5] Fdn Dev Endocrinol, Cleveland, OH USA
[6] Brigham & Womens Hosp, Ctr Reprod Med, Boston, MA 02115 USA
[7] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Psychiat, Piscataway, NJ 08854 USA
[8] Watson Labs, Dept Clin Res, Salt Lake City, UT USA
[9] Univ Utah, Med Ctr, Dept Obstet & Gynecol, Salt Lake City, UT 84132 USA
[10] Abesta Corp, Salt Lake City, UT USA
关键词
D O I
10.1056/NEJM200009073431002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The ovaries provide approximately half the circulating testosterone in premenopausal women. After bilateral oophorectomy, many women report impaired sexual functioning despite estrogen replacement. We evaluated the effects of transdermal testosterone in women who had impaired sexual function after surgically induced menopause. Methods Seventy-five women, 31 to 56 years old, who had undergone oophorectomy and hysterectomy received conjugated equine estrogens (at least 0.625 mg per day orally) and, in random order, placebo, 150 mu g of testosterone, and 300 mu g of testosterone per day transdermally for 12 weeks each. Outcome measures included scores on the Brief Index of Sexual Functioning for Women, the Psychological General Well-Being Index, and a sexual-function diary completed over the telephone. Results The mean (+/- SD) serum free testosterone concentration increased from 1.2 +/- 0.8 pg per milliliter (4.2 +/- 2.8 pmol per liter) during placebo treatment to 3.9 +/- 2.4 pg per milliliter (13.5 +/- 8.3 pmol per liter) and 5.9 +/- 4.8 pg per milliliter (20.5 +/- 16.6 pmol per liter) during treatment with 150 and 300 mu g of testosterone per day respectively (normal range, 1.3 to 6.8 pg per milliliter [4.5 to 23.6 pmol per liter]). Despite an appreciable placebo response, the higher testosterone dose resulted in further increases in scores for frequency of sexual activity and pleasure orgasm in the Brief Index of Sexual Functioning for Women (P = 0.03 for both comparisons with placebo). At the higher dose, the percentages of women who had sexual fantasies masturbated, or engaged in sexual intercourse at least once a week increased two to three times from base line. The positive-well-being, depressed-mood, and composite scores of the Psychological General Well-Being Index also improved at the higher dose (P = 0.04, P = 0.03, and P = 0.04, respectively, for the comparison with placebo), but the scores on the telephone-based diary did not increase significantly. Conclusions In women who have undergone oophorectomy and hysterectomy transdermal testosterone improves sexual function and psychological well-being. (N Engl J Med 2000; 343: 682-8.) (C) 2000, Massachusetts Medical Society.
引用
收藏
页码:682 / 688
页数:7
相关论文
共 25 条